XBiotech Inc (XBIT)
8.49
+0.47
(+5.86%)
USD |
NASDAQ |
May 03, 16:00
8.39
-0.10
(-1.18%)
After-Hours: 20:00
XBiotech Price to Book Value: 1.181 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.181 |
| May 02, 2024 | 1.116 |
| May 01, 2024 | 1.135 |
| April 30, 2024 | 1.067 |
| April 29, 2024 | 1.080 |
| April 26, 2024 | 1.095 |
| April 25, 2024 | 1.142 |
| April 24, 2024 | 1.123 |
| April 23, 2024 | 1.138 |
| April 22, 2024 | 1.106 |
| April 19, 2024 | 1.119 |
| April 18, 2024 | 1.101 |
| April 17, 2024 | 1.128 |
| April 16, 2024 | 1.247 |
| April 15, 2024 | 1.309 |
| April 12, 2024 | 1.287 |
| April 11, 2024 | 1.322 |
| April 10, 2024 | 1.376 |
| April 09, 2024 | 1.290 |
| April 08, 2024 | 1.354 |
| April 05, 2024 | 1.142 |
| April 04, 2024 | 1.305 |
| April 03, 2024 | 1.170 |
| April 02, 2024 | 1.178 |
| April 01, 2024 | 1.092 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.131 |
| March 27, 2024 | 1.112 |
| March 26, 2024 | 1.109 |
| March 25, 2024 | 1.042 |
| March 22, 2024 | 1.044 |
| March 21, 2024 | 1.009 |
| March 20, 2024 | 0.9963 |
| March 19, 2024 | 0.9893 |
| March 18, 2024 | 0.9225 |
| March 15, 2024 | 0.8223 |
| March 14, 2024 | 0.8845 |
| March 13, 2024 | 0.8776 |
| March 12, 2024 | 0.8804 |
| March 11, 2024 | 0.8832 |
| March 08, 2024 | 0.8901 |
| March 07, 2024 | 0.8887 |
| March 06, 2024 | 0.8901 |
| March 05, 2024 | 0.8748 |
| March 04, 2024 | 0.8887 |
| March 01, 2024 | 0.8901 |
| February 29, 2024 | 0.8706 |
| February 28, 2024 | 0.8818 |
| February 27, 2024 | 0.8887 |
| February 26, 2024 | 0.8971 |
| February 23, 2024 | 0.8971 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3395
Minimum
Mar 16 2020
12.68
Maximum
Dec 24 2019
1.777
Average
1.173
Median
Apr 14 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.187 |
| Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
| PS Ratio | 64.45 |
| PEG Ratio | -0.0912 |
| Price | 8.49 |
| Earnings Yield | -9.66% |
| Market Cap | 258.53M |